(Q39111815)

9 September 2017

title

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). (English)

1 reference

9 September 2017

0 references

Patricia Fellows

1

1 reference

9 September 2017

Jeffrey Adamovicz

2

1 reference

9 September 2017

Justin Hartings

3

1 reference

9 September 2017

Robert Sherwood

4

1 reference

9 September 2017

William Mega

5

1 reference

9 September 2017

Trevor Brasel

6

1 reference

9 September 2017

Ed Barr

7

1 reference

9 September 2017

Lou Holland

8

1 reference

9 September 2017

Winston Lin

9

1 reference

9 September 2017

Amanda Rom

10

1 reference

9 September 2017

William Blackwelder

11

1 reference

9 September 2017

Jessica Price

12

1 reference

9 September 2017

Stephen Morris

13

1 reference

9 September 2017

Doris Snow

14

1 reference

9 September 2017

Mary Kate Hart

15

1 reference

9 September 2017

language of work or name

English

0 references

publication date

15 October 2010

1 reference

9 September 2017

1 reference

9 September 2017

volume

28

1 reference

9 September 2017

issue

49

1 reference

9 September 2017

page(s)

7748-7756

1 reference

Yersinia pestis--etiologic agent of plague

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Plague: past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Plague Immunization. V. Indirect Evidence for the Efficacy of Plague Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Plague Immunization. I. Past and Present Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Plague Immunization, II. Relation of Adverse Clinical Reactions to Multiple Immunizations with Killed Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Prospects for new plague vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

A parenteral DNA vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Protection against pneumonic plague following oral immunization with a non-replicating vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Development of a recombinant vaccine against aerosolized plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Current challenges in the development of vaccines for pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Immune defense against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Measurement of the respiratory volumes of laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.062

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.09.062

1 reference

9 September 2017

1 reference